Effect of maternal COVID-19 vaccination on mandibular molars development in albino rats offspring.

Effect of maternal COVID-19 vaccination on mandibular molars development in albino rats offspring.

Publication date: Sep 12, 2025

The aim of this study was to investigate the effect of maternal vaccination by coronavirus (COVID-19) vaccine on the development of mandibular first molar of albino rats offspring. Pregnant female rats were divided into control and vaccinated groups injected intramuscularly by 0. 035 mL of either saline or AstraZeneca vaccine, respectively. The offspring were examined through serology, histology, histomorphometric and PCR analysis. Vaccinated mothers and their offspring showed mean antibody concentrations of 92. 57 AU/mL and 100 AU/mL, respectively. Histologically, both groups were nearly at the same stages of odontogenesis on the third and ninth postnatal days. Higher bone deposition was quantified in the vaccinated group on the third and ninth postnatal days except below the tooth germ on the third day with statistically significant difference (p value ≤ 0. 05). Significant increases in expression of Receptor activator of nuclear factor ligand (RANKL) gene (3. 53 fold) and bone morphogenic protein-2 (BMP-2) gene (4. 76 fold) were noted on the ninth postnatal day. However, osteoprotegrin (OPG) gene was downregulated (0. 40 fold) on the ninth postnatal day with statistically significant differences (p value ≤ 0. 05) between both groups. We conclude that AstraZeneca vaccine administration during pregnancy is generally safe regarding the teeth development in the offspring.

Open Access PDF

Concepts Keywords
Bone BMP-2
Coronavirus COVID-19
Pcr Development
Postnatal OPG
Pregnant RANKL
Real time PCR
Vaccine

Semantics

Type Source Name
disease MESH COVID-19
disease IDO protein
drug DRUGBANK Dibotermin alfa
drug DRUGBANK Amlodipine
drug DRUGBANK Coenzyme M
disease IDO replication
drug DRUGBANK Alteplase
disease IDO production
disease MESH infection
disease MESH preeclampsia
disease MESH postpartum hemorrhage
drug DRUGBANK Water
disease MESH abnormalities
disease IDO blood
drug DRUGBANK Formaldehyde
drug DRUGBANK Edetic Acid
disease MESH inflammation
disease MESH weight gain
disease MESH seroconversion
disease IDO cell
disease IDO susceptibility
disease IDO process
drug DRUGBANK Parathyroid hormone
pathway REACTOME Immune System
disease MESH cytokine storm
drug DRUGBANK Isoxaflutole
pathway REACTOME Interferon Signaling
disease MESH Oxidative stress
disease MESH viral infections
disease MESH vitamin deficiency
drug DRUGBANK Ethanol
disease MESH necrosis
disease MESH long COVID
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH periodontitis
drug DRUGBANK Efavirenz
pathway REACTOME Reproduction

Original Article

(Visited 8 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *